Credit Suisse’s Fibrocell Science Inc. FCSC Stock Holding History

Credit Suisse’s Portfolio FCSC Stock Details FCSC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-5,842	Closed	-$101K	–	4337
2016 Q2	$101K	Buy	5,842 +5,013	+605%	+$156K	﹤0.01%	4061
2016 Q1	$31K	Buy	+829	New	+$33.1K	﹤0.01%	3920
2015 Q2	–	Sell	-2,834	Closed	-$192K	–	4699
2015 Q1	$192K	Buy	+2,834	New	+$183K	﹤0.01%	4101
2014 Q3	–	Sell	-1,980	Closed	-$118K	–	4749
2014 Q2	$118K	Buy	1,980 +1,203	+155%	+$67.1K	﹤0.01%	4508
2014 Q1	$61K	Sell	777 -11	-1%	-$853	﹤0.01%	4565
2013 Q4	$48K	Buy	+788	New	+$45.9K	﹤0.01%	4533

Other funds holding FCSC

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HVC

Healthcare Value Capital Woodcliff Lake, New Jersey $50.7M AUM 24.72% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Credit Suisse's FCSC Position: Q3 2016 in Review

Credit Suisse sold out of Fibrocell Science Inc. (FCSC) in Q3 2016, closing a stake of 5,842 shares — an estimated $101K sold.

Credit Suisse first reported a position in FCSC in Q4 2013 and held it in 6 quarters. The position peaked at $192K in Q1 2015. 37 funds tracked by Wall St. Rank hold FCSC as of Q3 2016.

Credit Suisse reported no remaining Fibrocell Science Inc. position as of Q3 2016 after selling out during the quarter.
Credit Suisse sold 5,842 Fibrocell Science Inc. shares in Q3 2016, an estimated $101K.
Credit Suisse first reported a position in Fibrocell Science Inc. in Q4 2013 and held it in 6 quarters.
Credit Suisse's Fibrocell Science Inc. position peaked at $192K in Q1 2015.
37 funds tracked by Wall St. Rank held Fibrocell Science Inc. as of Q3 2016.

Based on Credit Suisse's 13F filing for Q3 2016, filed 15 Nov 2016.